Chengdu Huasun Group Inc Ltd

SHE:000790 China Drug Manufacturers - Specialty & Generic
Market Cap
$356.18 Million
CN¥2.61 Billion CNY
Market Cap Rank
#13060 Global
#3328 in China
Share Price
CN¥4.19
Change (1 day)
+0.72%
52-Week Range
CN¥3.39 - CN¥4.55
All Time High
CN¥21.66
About

Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of … Read more

Chengdu Huasun Group Inc Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.31%

Chengdu Huasun Group Inc Ltd (000790) has an Asset Resilience Ratio of 0.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥6.56 Million
Cash + Short-term Investments
Total Assets
CN¥2.09 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (1995–2024)

This chart shows how Chengdu Huasun Group Inc Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Chengdu Huasun Group Inc Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥6.56 Million 0.31%
Total Liquid Assets CN¥6.56 Million 0.31%

Asset Resilience Insights

  • Limited Liquidity: Chengdu Huasun Group Inc Ltd maintains only 0.31% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Chengdu Huasun Group Inc Ltd Industry Peers by Asset Resilience Ratio

Compare Chengdu Huasun Group Inc Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biostar Pharmaceuticals Inc
PINK:BSPM
Drug Manufacturers - Specialty & Generic 0.00%
High Sierra Technologies Inc
PINK:HSTI
Drug Manufacturers - Specialty & Generic 0.01%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%

Annual Asset Resilience Ratio for Chengdu Huasun Group Inc Ltd (1995–2024)

The table below shows the annual Asset Resilience Ratio data for Chengdu Huasun Group Inc Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.29% CN¥6.56 Million CN¥2.25 Billion -1.66pp
2020-12-31 1.95% CN¥22.23 Million CN¥1.14 Billion -1.90pp
1996-12-31 3.85% CN¥7.11 Million CN¥184.48 Million -1.62pp
1995-12-31 5.48% CN¥8.64 Million CN¥157.76 Million --
pp = percentage points